Kinnate Biopharma Stock Forecast - Accumulation Distribution
| KNTEDelisted Stock | USD 2.96 0.27 8.36% |
Kinnate Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast Kinnate Biopharma stock prices and determine the direction of Kinnate Biopharma's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Kinnate Biopharma's historical fundamentals, such as revenue growth or operating cash flow patterns.
Kinnate |
| Previous Accumulation Distribution | Accumulation Distribution | Trend |
| 49191.79 | 37329.34 |
| Check Kinnate Biopharma Volatility | Backtest Kinnate Biopharma | Trend Details |
Kinnate Biopharma Trading Date Momentum
| On July 03 2023 Kinnate Biopharma was traded for 3.01 at the closing time. The top price for the day was 3.08 and the lowest listed price was 2.93 . The trading volume for the day was 204.4 K. The trading history from July 3, 2023 was a factor to the next trading day price decrease. The trading delta at closing time against the next closing price was 0.66% . The trading delta at closing time against the current closing price is 1.32% . |
Accumulation distribution indicator can signal that a trend is either nearing completion, at a continuation, or is about to break-outs. The actual value of this indicator is of no significance. What is significant is the change in value of over time. The formula for A/D of a given trading day can be expressed as follow: ((Close - Low) - (High - Close)) / (High - Low) X Volume
Compare Kinnate Biopharma to competition
View Kinnate Biopharma Related Equities
| Risk & Return | Correlation |
Kinnate Biopharma Market Strength Events
Market strength indicators help investors to evaluate how Kinnate Biopharma stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Kinnate Biopharma shares will generate the highest return on investment. By undertsting and applying Kinnate Biopharma stock market strength indicators, traders can identify Kinnate Biopharma entry and exit signals to maximize returns.
Kinnate Biopharma Risk Indicators
The analysis of Kinnate Biopharma's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Kinnate Biopharma's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting kinnate stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 4.52 | |||
| Standard Deviation | 5.59 | |||
| Variance | 31.27 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Other Consideration for investing in Kinnate Stock
If you are still planning to invest in Kinnate Biopharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Kinnate Biopharma's history and understand the potential risks before investing.
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |